Ginkgo Bioworks Holdings, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-44.7M | $-66.9M | $22.2M | $771.0K |
| FY2020 | $-135.8M | $-193.7M | $57.8M | $476.0K |
| FY2021 | $-253.8M | $-310.3M | $56.5M | $1.61B |
| FY2022 | $-252.2M | $-304.5M | $52.3M | $1.93B |
| FY2023 | $-295.5M | $-336.3M | $40.8M | $229.9M |
| FY2024 | $-319.6M | $-382.1M | $62.5M | $112.3M |
| FY2025 | $-171.1M | $-178.7M | $7.7M | $81.5M |